Gate News reports that on March 26, a federal grand jury in Ohio, USA, indicted two Chinese pharmaceutical companies (Shandong Believe Chemical Company Pte Ltd. and Shandong Ranhang Biotechnology Co. Ltd.) and six Chinese nationals. The prosecution alleges that the defendants sold substances, including dexmedetomidine, to U.S. and overseas drug traffickers as fentanyl diluents, and instructed customers to pay via their controlled cryptocurrency wallets, with funds subsequently layered and transferred to overseas financial institutions. The case was driven by FBI’s “Operation Box Cutter.” Three defendants are also charged with attempting to provide material support to a Mexican drug cartel designated as a foreign terrorist organization. If convicted, the defendants face up to life imprisonment for drug trafficking, as well as up to 20 years for money laundering and terrorism-related charges.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
